Full Text Journal Articles from
Abstract 31085944

Advertisement

Find full text journal articles








Dietary supplementation with fish oil reverses high fat diet-induced enhanced sensitivity to the behavioral effects of quinpirole.

PMID: 31085944 (view PubMed database entry)
DOI: 10.1097/fbp.0000000000000439 (read at publisher's website )

Caroline Hernandez-Casner, Claudia J Woloshchuk, Carli Poisson, Samirah Hussain, Jeremiah Ramos, Katherine M Serafine,

Department of Psychology.

Consuming a high fat diet can lead to many negative health consequences, such as obesity, insulin resistance, and enhanced sensitivity to drugs acting on dopamine systems. It has recently been demonstrated that dietary supplementation with fish oil, which is rich in omega-3 fatty acids, can prevent this high fat diet-induced enhanced sensitivity to dopaminergic drugs from developing. However, it is not known whether fish oil supplementation can reverse this effect once it has already developed. To test the hypothesis that dietary supplementation with fish oil will reverse high fat diet-induced enhanced sensitivity to quinpirole, a dopamine D2/D3 receptor agonist, male Sprague-Dawley rats were fed either standard chow (17% kcal from fat), high fat chow (60% kcal from fat), standard chow, or high fat chow supplemented with 20% (w/w) fish oil. Body weight, food consumption, and sensitivity to quinpirole-induced (0.0032-0.32 mg/kg) penile erections were examined throughout the course of the experiment. Eating high fat chow enhanced sensitivity of rats to quinpirole-induced penile erections (i.e. resulted in a leftward shift of the ascending limb of the dose-response curve). Dietary supplementation with fish oil successfully treated this effect, as dose-response curves were not different for rats eating standard chow and rats eating high fat chow with fish oil. These results suggest that in addition to preventing the negative health consequences of eating a high fat diet, fish oil can also reverse some of these consequences once they have developed.

Behav Pharmacol (Behavioural pharmacology)
[2019, 30(4):370-375]

Cited: 0 times

AltMetric Statistics
Authors' Affiliation
Map for Author Affiliation





Advertisement

Disclaimer
0.6189 s